What We're Reading: Page 197
Industry reads hand-picked by our editors
Apr 20, 2020
Apr 17, 2020
-
STAT
Early peek at data on Gilead coronavirus drug suggests coronavirus patients are responding to treatment
-
LifeSciVC
Value Creation And Destruction: Dispersion of Performance In Biotech IPOs
-
Axios
Coronavirus testing is plateauing, while state testing varies widely
-
CNBC
If Sanofi's coronavirus vaccine works, CEO says it can produce up to 600 million doses next year
Apr 16, 2020
-
The Washington Post
Chaotic search for coronavirus treatments undermines efforts, experts say
-
Bloomberg
Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally
-
In the Pipeline
Coronavirus Vaccine Prospects
-
STAT
Scientists tap CRISPR to create a rapid Covid-19 test
Apr 15, 2020
-
The Atlantic
Our Pandemic Summer
-
The Wall Street Journal
U.S. to Cut Funding to World Health Organization Over Coronavirus Response
-
OneZero
New Testing Tech Could Stop the Next Pandemic
-
POLITICO
FEMA ships out nearly 20 million hydroxychloroquine tablets
Apr 14, 2020
-
The Wall Street Journal
The 49ers Lost the Super Bowl and May Have Saved Lives
-
STAT
Who gets the last ventilator? Pondering the unthinkable amid Covid-19
-
Bloomberg
Stay Home During Outbreak: Americans Stick to Social Distancing
-
The New York TImes
Who Is Immune to the Coronavirus?
Apr 13, 2020
-
The New York Times
How Biogen Became a Coronavirus 'Superspreader'
-
The Wall Street Journal
Trump Retweets Call for Dr. Fauci to Be Fired Over Coronavirus Comments
-
Endpoints
Judge slaps enhanced damages on Gilead/Kite for 'willful' patent violation, boosting award to a blockbuster $1.2B
-
Kaiser Health News
A Colorado Ski Community Planned To Test Everyone For COVID-19. Here’s What Happened.
Previous
